UNLIMITED

NPR

Pricey New Cholesterol Drug's Effect On Heart Disease Is More Modest Than Hoped

The injectible drug Repatha is spectacularly good at lowering cholesterol. But the first big clinical trial of its ability to prevent heart attack and stroke finds smaller benefits.
Source: Dan Woodruff

Another cardiology meeting, another big prevention trial – and questions abound. People at risk for cardiovascular disease will be wondering about the implications for them. So are the doctors. New trials take some time to digest – and yet our news cycle wants quick, succinct answers. Sometimes it is not an easy call.

So here is what happened. For the past couple of years, experts in prevention have debated the merits of two new drugs, evolocumab and alirocumab (known as Repatha and Praluent), that were approved by the FDA in 2015 for the treatment of high cholesterol.

These drugs, which emerged from some very clever basic science, were distinctive in that they simulated a favorable genetic variation and

You’re reading a preview, subscribe to read more.

More from NPR

NPR1 min read
The Magic Of Hallmark Holiday Movies
It's winter. You throw on your coat and favorite scarf and head outside to put up some last-minute decorations. Stepping out onto your porch, you gaze into the sky just as wispy flakes begin to fall. You smile to yourself because there's no such thin
NPR1 min read
A Good Guy: 279 Hours
Today, the first of a two-part investigation from NPR's Embedded.Sgt. Joshua Abate's career in the Marine Corps seemed to be taking off. He was about to start a top-clearance internship at the NSA. But first, he had to take a standard polygraph test.
NPR1 min read
The Indicators Of This Year And Next
This year, there was some economic good news to go around. Inflation generally ticked down. Unemployment more or less held around 4-percent. Heck, the Fed even cut interest rates three times. But for a lot of people, the overall economic vibes were m

Related Books & Audiobooks